Worldwide sales of homeopathic drug products are estimated at some 6 billion French francs ($1.15 billion), and France alone now accounts for sales of 1.5 billion francs.
Boiron is market leader with 60%, followed by Dolisos with an estimated 25% and Lehning with 5%. These firms report constantly rising sales, increasing from 500 million francs in 1982 to 1.6 billion francs in 1993, or 2.2% of the French drug market compared with 1.2% of the European and 1% of the world market.
A new survey of the sector by Ifop is now underway, but the last poll, in 1994, showed that 75% of the public said they were in favor of homeopathy.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze